Literature DB >> 3958707

Urinary norepinephrine excretion in panic and phobic disorders.

F Dajas, A Nin, L Barbeito.   

Abstract

Morning urinary norepinephrine (NE) was assessed in 36 patients suffering from panic and phobic disorders according to DSM III. Urinary NE excretion was significantly higher in this group than in a normal control one. Phobic patients excreted lower levels of NE than panic ones. No significant association was found between urinary NE levels and anxiety scores according to Zung's Anxiety Status Inventory or Wittenborn Psychiatric Rating Scale. The NE increase is interpreted as reflecting a sympathetic nervous system hyperactivity in anxiety. A concomitant effect upon NE metabolism of benzodiazepine withdrawal cannot be discarded since the group of patients previously medicated showed the highest NE excretion.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3958707     DOI: 10.1007/bf01249613

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  17 in total

1.  Resting plasma catecholamine concentrations in patients with depression and anxiety.

Authors:  R J Wyatt; B Portnoy; D J Kupfer; F Snyder; K Engelman
Journal:  Arch Gen Psychiatry       Date:  1971-01

2.  A rating instrument for anxiety disorders.

Authors:  W W Zung
Journal:  Psychosomatics       Date:  1971 Nov-Dec       Impact factor: 2.386

Review 3.  Current concepts in psychiatry. Panic attacks and phobias.

Authors:  D V Sheehan
Journal:  N Engl J Med       Date:  1982-07-15       Impact factor: 91.245

4.  The relationship of plasma free MHPG to anxiety and psycho-physical pain in normal volunteers.

Authors:  T W Uhde; L J Siever; R M Post; D C Jimerson; J P Boulenger; M S Buchsbaum
Journal:  Psychopharmacol Bull       Date:  1982-10

5.  The locus coeruleus: actions of psychoactive drugs.

Authors:  H R Olpe; R S Jones; M W Steinmann
Journal:  Experientia       Date:  1983-03-15

6.  CSF and urinary biogenic amines and metabolites in depression and mania. A controlled, univariate analysis.

Authors:  S H Koslow; J W Maas; C L Bowden; J M Davis; I Hanin; J Javaid
Journal:  Arch Gen Psychiatry       Date:  1983-09

7.  Noradrenergic function in panic anxiety. Effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder.

Authors:  D S Charney; G R Heninger; A Breier
Journal:  Arch Gen Psychiatry       Date:  1984-08

Review 8.  Differential diagnosis and treatment of panic attacks and phobic states.

Authors:  M R Liebowitz; D F Klein
Journal:  Annu Rev Med       Date:  1981       Impact factor: 13.739

9.  Resting urinary catecholamine excretion in schizophrenics: methodology and interpretation of results.

Authors:  L Barbeito; A Lista; R Silveira; F Dajas
Journal:  Biol Psychiatry       Date:  1984-10       Impact factor: 13.382

10.  High urinary norepinephrine excretion in major depressive disorders: effects of a new type of MAO inhibitor (Moclobemide, RO 11-1163).

Authors:  F Dajas; A Lista; L Barbeito
Journal:  Acta Psychiatr Scand       Date:  1984-11       Impact factor: 6.392

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.